Scientists found "immortal" jellyfish, scholars reveal the mechanism of aging, and human life expectancy may be extended again.

Earlier scientists discovered that lighthouse jellyfish, under certain conditions, will degenerate into a juvenile state and then grow into a new jellyfish, achieving immortality by so-called "turning back the clock". Like ordinary jellyfish, lighthouse jellyfish reproduce sexually and die after laying eggs, but the difference is that they can "revert" to their initial hydroid state after they grow up.

If jellyfish can "grow back", can humans do the same? The answer is no, of course, unless you want to become a giant jellyfish with human DNA. But even so, the wealthy, who are more than a little obsessed with "immortality", is taking a big step forward and even a different approach to things like "life extension", preferring to believe that humans will eventually find a way to beat death.

Silicon Valley tycoon develops "immortality" drug, throws thousands of dollars for "immortality"

Larry Ellison is the owner of Oracle, the world's largest database software company, and his products are distributed around the world. Like most rich people, Oracle Software CEO Larry Ellison also wants to live a long life. For this reason, Ellison created a medical foundation - the Ellison Medical Foundation, dedicated to the development of anti-aging drugs. Not only that Ellison's namesake foundation has donated $100 million to polio eradication, and in response to a reporter's question about why he continues to invest tens of billions of dollars in anti-aging research, he said, "Death makes me angry."

In addition to Ellison, Facebook founders Mr. and Mrs. Zuckerberg continue to invest $3 billion, seeking to enable scientists to achieve effective intervention and management of all diseases in the 21st century; food tycoon Mercado invested $500 million to build an institution specializing in longevity and healthy diet research, wanting to live to 125 years old. Under the impetus of heavy money, life technology has accelerated its iteration, and the dream of the rich to spend thousands of dollars just to "live forever" seems to become reality step by step, including some amazing achievements in the field of biotechnology.

Breakthrough in biotechnology, time factor dramatically extends the life span of mice

As early as 2013, Harvard Medical School genetics professor Sinclair was the first to announce a beta-nicotinamide derivative (the core mechanism component of the popular high-net-worth group, Paxos), which can effectively supplement the important coenzyme I in the human body, which decreases with age and is believed to be an important cause of accelerated aging in humans. By administering this beta-nicotinamide derivative, the cellular metabolism and related aging indicators of the experimental subjects were improved and even extended the survival period by one-third, which is about 30 years of additional human life span. Professor Sinclair himself has been selected by TIME as one of the "100 Most Influential People in the World" for his outstanding contributions to the field of anti-aging.

As the mechanism of action of this β-nicotinamide derivative related to aging and longevity continued to be explored, well-known academic journals such as Cell published articles on it, and the substance also quickly attracted the interest of many wealthy people, but at that time, due to the high cost of production and purification, only a few people had access to it because it could only be obtained through individual laboratories. The first group of people to eat the "crab" was the researcher represented by Sinclair himself.

It is revealed that Superman Lee had in 2017 through personal channels to get to try Park Aos beta-nicotinamide precursor, claiming to feel 20 years younger after spending 200 million shares in the relevant technology company. Sinclair's father is 80 years old and adheres to taking a period after still carrying out their youth on his favorite mountain surfing sports, the physical state is shown and the same age is very different.

With the exposure of many academic kinds of literature and media reports, this beta-nicotinamide derivative and its anti-aging mechanism are gradually becoming known to the public. It is reported that BOS has successfully achieved the mass production of this substance through green enzyme targeting technology, so that it can finally flow into the hands of the majority of high net worth people outside of a few wealthy people, but the cost of taking it is still not low. According to the big data of consumption represented by Jingdong, the substance and keywords such as Paxos have become the hot search words on the platform, and the total number of intention groups harvested is hundreds of thousands.

Aging intervention pushes 100 billion markets, further widening the gap between rich and poor life expectancy

The huge breakthrough brought by the field of life science and technology has given beta-nicotinamides the potential of a 100 billion dollar market. Merrill Lynch, a leading investment bank, believes that a huge $600 billion market is expected to be achieved in 2015, and Sinclair himself, the lead scientist of the substance, is planning to raise another $100 million to further expand the substance's research related to aging and lifespan intervention after achieving $50 million in Series B financing, and it is reported that the earlier $50 million financing has brought his biotech company The earlier $50 million funding round is said to have brought his biotech company a valuation of about $500 million.

Returning to the biotechnology results themselves, the promise of the aging and lifespan intervention mechanism is right up the rich man's alley. Property tycoon Lee Shau-kee once said without fear of contradiction that he would "trade $100 billion for 30 years of youth". The cycle of wealth and longevity, with the help of increasingly cutting-edge science and technology, is gradually manifesting itself in the rich having a longer life expectancy than the average person. Stanford University study found that the average life expectancy of the top 1% of the United States wealthy reached 87.3 years, more than the average life expectancy of the top 1%, more than 15 years.

According to the Darwinian evolutionary theory of survival of the fittest, we are in an era of rapid technological development, under the support of wealth and life extension black technology, a group of rich people will be the first to break through the ceiling of life expectancy, wealth is becoming an important factor affecting life expectancy, then the rich and ordinary people may further widen the gap between life expectancy, and those who do not have the opportunity to enjoy the fruits of science and technology and where to go, this is a question worth thinking about. This is a question worth thinking about.